Eleftheria Kampouri

University of Lausanne

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Andrew Portuguese

Assistant Professor

Fred Hutch Cancer Center

UNITED STATES

View details

Matthaios Papadimitriou-Olivgeris

Lausanne University Hospital

SWITZERLAND

View details

Guy Handley

Assistant Professor

University of South Florida

UNITED STATES

View details

Maria Dioverti Prono

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Aline Munting

Chief resident

Centre Hospitalier Universitaire Vaudois

SWITZERLAND

View details

Paraskevas Filippidis

Yale University

UNITED STATES

View details

Margaret Green

Clinical Associate Professor

University of Washington

UNITED STATES

View details

Damian Green

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eleftheria Kampouri

Research Interests

Explore related searches

Contact this professor

Articles (10)

CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape

Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?

Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort

COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis

Collaborators (8)

Andrew Portuguese

Matthaios Papadimitriou-Olivgeris

Guy Handley

Maria Dioverti Prono

Aline Munting

Paraskevas Filippidis

Margaret Green

Damian Green

Make your next move.